Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents - Trial 2014-005134-64

Name: Clinical Trial 2014-005134-64
Creator: Bristol-Myers Squibb Company
Keywords: HIV Infections, clinical trial

Access comprehensive clinical trial information for 2014-005134-64 through Pure Global AI's free database. This phase not specified trial is sponsored by Bristol-Myers Squibb Company and is currently status unknown. The study focuses on HIV Infections.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2014-005134-64

Trial Details

EU Clinical Trials Register • 2014-005134-64

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Study Focus

Disease/Condition

HIV Infections

Sponsor & Location

Primary Sponsor

Bristol-Myers Squibb Company

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

For Step 1:

ICD-10 Classifications

HIV disease resulting in other viral infections

Human immunodeficiency virus [HIV] disease

HIV disease resulting in other bacterial infections

Acute HIV infection syndrome

Unspecified human immunodeficiency virus [HIV] disease

Data Source

Registry

EU Clinical Trials Register

Trial ID

2014-005134-64

Type

Non-Device Trial